Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity is for a maximum of 10.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 10.25 Contact Hours.
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.
This activity is supported by a educational grants from AstraZeneca, Helsinn Therapeutics (U.S.), Inc., Novartis Pharmaceuticals Corporation, and Taiho Oncology.
August 4-5, 2017
Loews Vanderbilt Hotel
2100 West End Avenue
Nashville, TN 37203
The 1st Annual School of Nursing Oncology™ will provide the latest information on key topics in oncology that can readily be applied to nursing clinical practice in a variety of settings. Our faculty will discuss strategies help to optimize patient management and provide insight into the evolving treatment landscape. Nursing professionals frequently encounter barriers to the optimal delivery of care for patients with cancer, and this program is designed to answer questions in a manner that will facilitate the overcoming of those barriers. This will be a dynamic experience, allowing participants to engage with faculty as they share their perspectives and personal experiences on clinical challenges commonly encountered in nursing practice. A variety of formats will be used to generate an exciting learning environment, including a mixture of didactic presentations, interactive discussion, and case-based learning opportunities.
This educational program is directed toward nurses interested in the management of patients with cancer. Other health care professionals interested in the management of patients with cancer are also invited to attend.
At the conclusion of this symposium, you should be better prepared to:
ASH: Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients with GvHD
December 8, 2017
ASH: Evaluating the Emerging Role of Biosimilar Agents for the Treatment of Hematologic Malignancies
December 8, 2017
Addressing Challenges and Personalizing Care in Postsurgical Pain Management - Brunch With the Experts
Dec 29, 2017